Fig. 2.
Fig. 2. Signal transduction characteristics of cEPOR mutants in BaF3 cells. (A) Whole cell lysates of the BaF3 transfectants described in Fig 1 were subjected to immunoprecipitation with anti-JAK2 antiserum followed by separation by polyacrylamide gel electrophoresis and immunoblotting analysis with anti-phosphotyrosine antibody. Cells were either resting (0) or stimulated with EPO at low-dose (1, 1 U/mL) or high-dose (10, 10 U/mL) EPO for 15 minutes before lysis. The blots were reprobed with anti-JAK2 antibody to verify the identity of the phosphoprotein band and equivalent gel loading (not shown). (B) Nuclear extracts prepared from resting or EPO-stimulated BaF3 cell lines were prepared and subjected to EMSA with an oligonucleotide probe containing a STAT-binding sequence (FcγRI). Supershift analysis with anti-STAT5 antisera was used to confirm the identity of the STAT within the retarded nucleoprotein complex (not shown). (C) Whole cell extracts prepared from resting (0) or EPO-stimulated (1 U/mL or 25 U/mL, as indicated) BaF3 cell lines were prepared and subjected to in vitro kinase assays as described in Materials and Methods.

Signal transduction characteristics of cEPOR mutants in BaF3 cells. (A) Whole cell lysates of the BaF3 transfectants described in Fig 1 were subjected to immunoprecipitation with anti-JAK2 antiserum followed by separation by polyacrylamide gel electrophoresis and immunoblotting analysis with anti-phosphotyrosine antibody. Cells were either resting (0) or stimulated with EPO at low-dose (1, 1 U/mL) or high-dose (10, 10 U/mL) EPO for 15 minutes before lysis. The blots were reprobed with anti-JAK2 antibody to verify the identity of the phosphoprotein band and equivalent gel loading (not shown). (B) Nuclear extracts prepared from resting or EPO-stimulated BaF3 cell lines were prepared and subjected to EMSA with an oligonucleotide probe containing a STAT-binding sequence (FcγRI). Supershift analysis with anti-STAT5 antisera was used to confirm the identity of the STAT within the retarded nucleoprotein complex (not shown). (C) Whole cell extracts prepared from resting (0) or EPO-stimulated (1 U/mL or 25 U/mL, as indicated) BaF3 cell lines were prepared and subjected to in vitro kinase assays as described in Materials and Methods.

Close Modal

or Create an Account

Close Modal
Close Modal